Photocure ASA (FRA:PHS)

Germany flag Germany · Delayed Price · Currency is EUR
6.54
0.00 (0.00%)
At close: Jan 9, 2026
31.33%
Market Cap172.27M
Revenue (ttm)45.87M
Net Income (ttm)180.73K
Shares Outn/a
EPS (ttm)0.01
PE Ratio953.16
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume400
Average Volume268
Open6.41
Previous Closen/a
Day's Range6.41 - 6.54
52-Week Range4.23 - 6.54
Betan/a
RSI58.53
Earnings DateFeb 18, 2026

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen... [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 101
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PHS
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.